[en] Adequate medication adherence is key for optimal benefit of pharmacological treatments. A wealth of research has been conducted to understand and identify opportunities to intervene to improve medication adherence, but variations in adherence definitions within prior research have led to ambiguity in study findings. The lack of a standard taxonomy hinders the development of cumulative science in adherence research. This article reviews the newly established Ascertaining Barriers to Compliance (ABC) taxonomy for medication adherence with a particular focus on its relevance and applicability within the context of asthma and chronic obstructive pulmonary disease management. Building on traditional definitions and concepts within medication adherence, the ABC taxonomy considers the temporal sequence of steps a patient must undertake to be defined as "adherent to treatment": (A) initiation, (B) implementation, and (C) persistence. We explain the clinical and research relevance of differentiating between these phases, point to differences in its applicability in observational and experimental research, review strengths and limitations of available measures, and highlight recent findings on specific determinants of these behaviors. Finally, we provide recommendations for research and practice with a view to supporting and sign posting opportunities to improve future respiratory medication adherence and associated research.
Disciplines :
Human health sciences: Multidisciplinary, general & others
Author, co-author :
Vrijens, Bernard ; Université de Liège - ULiège > Département des sciences de la santé publique
Dima, Alexandra L; Amsterdam School of Communication Research ASCoR, University of Amsterdam, Amsterdam, The Netherlands
Van Ganse, Eric; Pharmaco-Epidemiology Lyon (PEL), HESPER, Claude Bernard University, Lyon, France, Respiratory Medicine, Croix-Rousse University Hospital, Lyon, France
van Boven, Job F M; Department of Primary Care, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Eakin, Michelle N; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, Baltimore, Md
Foster, Juliet M; Woolcock Institute of Medical Research, Clinical Management Group, University of Sydney, Sydney, Australia
de Bruin, Marijn; Amsterdam School of Communication Research ASCoR, University of Amsterdam, Amsterdam, The Netherlands, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK
Chisholm, Alison; Respiratory Effectiveness Group, Cambridge, UK
Price, David ; Respiratory Effectiveness Group, Cambridge, UK, Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK
Language :
English
Title :
What We Mean When We Talk About Adherence in Respiratory Medicine.
Publication date :
2016
Journal title :
Journal of Allergy and Clinical Immunology: In Practice
ISSN :
2213-2198
eISSN :
2213-2201
Publisher :
American Academy of Allergy, Asthma and Immunology, United States
1 Global Initiative for Asthma. GINA Report, Global Strategy for Asthma Management and Prevention; 2014. Available from: http://ginasthma.org/. Accessed December 28, 2015.
2 Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Diagnosis, Management, and Prevention of COPD; 2016. Available from: http://goldcopd.org/. Accessed December 28, 2015.
3 The Global Asthma Network, The Global Asthma Report 2014. 2014, Global Asthma Network, Auckland, New Zealand.
4 Guarascio, A.J., Ray, S.M., Finch, C.K., Self, T.H., The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res 5 (2013), 235–245.
5 Blaschke, T.F., Osterberg, L., Vrijens, B., Urquhart, J., Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol 52 (2012), 275–301.
6 Roche, N., Reddel, H.K., Agusti, A., Bateman, E.D., Krishnan, J.A., Martin, R.J., et al. Integrating real-life studies in the global therapeutic research framework. Lancet Respir Med 1 (2013), e29–e30.
7 Vrijens, B., Urquhart, J., Methods for measuring, enhancing, and accounting for medication adherence in clinical trials. Clin Pharmacol Ther 95 (2014), 617–626.
8 World health Organization. Manifesto on Adherence to Asthma Treatment in Respiratory Allergy. Available from: http://www.worldallergy.org/UserFiles/file/GWCManifestoAdherenceChicago_fullpage.pdf. Accessed December 28, 2015.
9 Vrijens, B., De Geest, S., Huges, D.A., Przemyslaw, K., Demonceau, J., Ruppar, T., et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 73 (2012), 691–705.
10 Karve, S., Cleves, M.A., Helm, M., Hudson, T.J., West, D.S., Martin, B.C., Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin 25 (2009), 2303–2310.
11 Center for Health Policy Research, Adherence to HIV Therapy: Building a Bridge to Success Forum for Collaborative HIV Research. 1999, George Washington University Medical Center, Washington, DC.
12 Melani, A.S., Bonavia, M., Cilenti, V., Cinti, C., Lodi, M., Martucci, P., et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 105 (2011), 930–938.
13 World Health Organization. Adherence to Long-Term Therapies—Evidence for Action; 2003. Available from: http://apps.who.int/medicinedocs/pdf/s4883e/s4883e.pdf. Accessed October 21, 2015.
14 Cramer, J.A., Roy, A., Burrell, A., Fairchild, C.J., Fuldeore, M.J., Ollendorf, D.A., et al. Medication compliance and persistence: terminology and definitions. Value Health 11 (2008), 44–47.
15 Hutchins, D.S., Zeber, J.E., Roberts, C.S., Williams, A.F., Manias, E., Peterson, A.M., IPSOR Medication Adherence and Persistence Special Interest Group. Initial medication adherence-review and recommendations for good practices in outcomes research: an ISPOR medication adherence and persistence special interest group report. Value Health 18 (2015), 690–699.
16 Gardarsdottir, H., Souverein, P.C., Egberts, T.C., Heerdink, E.R., Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length. J Clin Epidemiol 63 (2010), 422–427.
17 Costello, R.W., Foster, J.M., Grigg, J., Eakin, M.N., Canonica, W., Yunus, F., et al. Seven stages of man—the role of age and cognition on medication adherence. J Allergy Clin Immunol Pract, 2016.
18 Dima, A.L., Hernandez, G., Cunillera, O., Ferrer, M., de Bruin, M., ASTRO-LAB group. Asthma inhaler adherence determinants in adults: systematic review of observational data. Eur Respir J 45 (2015), 994–1018.
19 Fischer, M.A., Stedman, M.R., Lii, J., Vogeli, C., Shrank, W.H., Brookhart, M.A., et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med 25 (2010), 284–290.
20 Barr, R.G., Celli, B.R., Martinez, F.J., Ries, A.L., Rennard, S.I., Reilly, J.J. Jr., et al. Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med, 118, 2005, 1415.
21 Restrepo, R.D., Alvarez, M.T., Wittnebel, L.D., Sorenson, H., Wettstein, R., Vines, D.L., et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis 3 (2008), 371–384.
22 Cole, S., Seale, C., Griffiths, C., ‘The blue one takes a battering’: why do young adults with asthma overuse bronchodilator inhalers? A qualitative study. BMJ Open, 3, 2013, e002247.
23 Price, D., David-Wang, A., Ho, J.C.-M., Jeong, J.W., Liam, C.K., Lin, J., et al., REALISE Asia Working Group. Time for a new language for asthma control: results from REALISE Asia. J Asthma Allergy 8 (2015), 93–103.
24 D'Arcy, S., MacHale, E., Seheult, J., Holmes, M.S., Hughes, C., Sulaiman, I., et al. A method to assess adherence in inhaler use through analysis of acoustic recordings of inhaler events. PLoS One, 9, 2014, e98701.
25 Van, Boven, Trappenburg, J.C., van der Molen, T., Chavannes, N.H., Towards tailored and targeted adherence assessment to optimise asthma management. NPJ Prim Care Respir Med, 25, 2015, 15046.
26 Nides, M., Tashkin, D.P., Simmons, M.S., Wise, R., Li, V.C., Rand, C.S., Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest 104 (1993), 501–507.
27 Bender, B., Wamboldt, F.S., O'Connor, S.L., Rand, C., Szefler, S., Milgrom, H., et al. Measurement of children's asthma medication adherence by self-report, mother report, canister weight, and Doser CT. Ann Allergy Asthma Immunol 85 (2000), 416–421.
28 Simmons, M.S., Nides, M.A., Rand, C.S., Wise, R.A., Tashkin, D.P., Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest 118 (2000), 290–295.
29 Dima, A., Souverein, P., Koster, P., Chisholm, A., Price, D., Colice, G., REG study: real-life, longitudinal ICS adherence patterns in a UK asthma population. Eur Respir J, 46(Suppl 59), 2015, 1238.
30 Horne, R., Weinman, J., Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health 17 (2002), 17–32.
31 Morisky, D.E., Green, L.W., Levine, D.M., Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24 (1986), 67–74.
32 Stirratt, M.J., Dunbar-Jacob, J., Crane, H.M., Simoni, J.M., Czajkowski, S., Hilliard, M.E., et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med 5 (2015), 470–482.
33 Kardas, P., Lewek, P., Matyjaszczyk, M., Determinants of patient adherence: a review of systematic reviews. Pharm Med Outcomes Res, 4, 2013, 91.
34 Laforest, L., Van Ganse, É., Devouassoux, G., Chatté, G., Tamberou, C., Belhassen, M., et al. Deliberate interruptions and changes of dose of inhaled corticosteroids by asthma patients: “a community pharmacy study”. Rev Mal Respir 32 (2015), 8–17.
35 Foster, J.M., Smith, L., Bosnic-Anticevich, S.Z., Usherwood, T., Sawyer, S.M., Rand, C.S., et al. Identifying patient-specific beliefs and behaviours for conversations about adherence in asthma. Intern Med J 42 (2012), e136–e144.
36 Laforest, L., Denis, F., Van Ganse, E., Ritleng, C., Saussier, C., Passante, N., et al. Correlates of adherence to respiratory drugs in COPD patients. Prim Care Respir J 19 (2010), 148–154.
37 Westerik, J.A., Carter, V., Chrystyn, H., Burden, A., Thompson, S.L., Ryan, D., et al. Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting. J Asthma 53 (2016), 231–239.
38 Giraud, V., Roche, N., Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 19 (2002), 246–251.
39 Braido, F., Chrystyn, H., Baiardini, I., Bosnic-Anticevich, S., van der Molen, T., Dandurand, R.J., et al. “Trying, But failing” - the role of inhaler technique and mode of delivery in respiratory medication adherence. J Allergy Clin Immunol Pract 4 (2016), 823–832.
40 Yeaw, J., Benner, J.S., Walt, J.G., Sian, S., Smith, D.B., Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm 15 (2009), 728–740.
41 Steinberg, S.C., Faris, R.J., Chang, C.F., Chan, A., Tankersley, M.A., Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study. Clin Drug Investig 30 (2010), 89–100.
42 Covvey, J.R., Mullen, A.B., Ryan, M., Steinke, D.T., Johnston, B.F., Wood, F.T., et al. A comparison of medication adherence/persistence for asthma and chronic obstructive pulmonary disease in the United Kingdom. Int J Clin Pract 68 (2014), 1200–1208.
43 Bereznicki, B.J., Peterson, G.M., Jackson, S.L., Walters, H., Hardley, F.L., Gavagna, G.A., et al. Describing drivers of and barriers to persistence with tiotropium in patients with chronic obstructive pulmonary disease: a mixed-methods approach. Int J Pharm Pract 23 (2015), 154–157.
44 Tanaka, K., Kamiishi, N., Miyata, J., Kabata, H., Masaki, K., Ogura-Tomomatsu, H., et al. Determinants of long-term persistence with tiotropium bromide for chronic obstructive pulmonary disease. COPD 12 (2015), 233–239.
45 Laforest, L., Licaj, I., Devouassoux, G., Hartwig, S., Marvalin, S., Van Ganse, E., Factors associated with early adherence to tiotropium in chronic obstructive pulmonary disease. Chron Respir Dis 10 (2013), 11–18.
46 Yu, A.P., Guérin, A., Ponce de Leon, D., Ramakrishnan, K., Wu, E.Q., Mocarski, M., et al. Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers. J Med Econ 14 (2011), 486–496.
47 Cramer, J.A., Bradley-Kennedy, C., Scalera, A., Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. Can Respir J 14 (2007), 25–29.
48 Bender, B.G., Pedan, A., Varasteh, L.T., Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol 118 (2006), 899–904.
49 Poulos, L.M., Ampon, R.D., Marks, G.B., Reddel, H.K., Inappropriate prescribing of inhaled corticosteroids: are they being prescribed for respiratory tract infections? A retrospective cohort study. Prim Care Respir J 22 (2013), 201–208.
50 Marceau, C., Lemière, C., Berbiche, D., Perreault, S., Blais, L., Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma. J Allergy Clin Immunol 118 (2006), 574–581.
51 Breekveldt-Postma, N.S., Koerselman, J., Erkens, J.A., van der Molen, T., Lammers, W.J., Herings, R.M.C., Treatment with inhaled corticosteroids in asthma is too often discontinued. Pharmacoepidemiol Drug Saf 17 (2008), 411–422.
52 van Boven, J.F.M., Ryan, D., Eakin, M.N., Canonica, G.W., Barot, A., Foster, J.M., et al. Enhancing respiratory medication adherence: the role of health care professionals and cost-effectiveness considerations. J Allergy Clin Immunol Pract 4 (2016), 835–846.
53 Dima, A.L., de Bruin, M., Van Ganse, E., ASTRO-LAB group. Mapping the asthma care process: implications for research and practice. J Allergy Clin Immunol Pract 4 (2016), 868–876.
54 Alili, M.E., Vrijens, B., Demonceau, J., Evers, S.M., Hiligsmann, M., A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. Br J Clin Pharmacol 82 (2016), 268–279.
55 Tourangeau, R., Rips, L.J., Rasinski, K., The Psychology of Survey Response. 2000, Cambridge University Press, Cambridge, United Kingdom.
56 Charles, C., Gafni, A., Whelan, T., Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making. Soc Sci Med 49 (1999), 651–661.
